Cannara Biotech Inc.
LOVE.V
TSX
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.58% | 17.99% | |||
| Total Other Revenue | -- | -179.10% | |||
| Total Revenue | 7.84% | 17.28% | |||
| Cost of Revenue | 17.81% | -0.52% | |||
| Gross Profit | -4.16% | 49.48% | |||
| SG&A Expenses | 7.90% | 3.89% | |||
| Depreciation & Amortization | -44.17% | 108.32% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.77% | 1.51% | |||
| Operating Income | -11.72% | 204.95% | |||
| Income Before Tax | -20.52% | 86.88% | |||
| Income Tax Expenses | 137.08% | -- | |||
| Earnings from Continuing Operations | -60.11% | 183.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -60.11% | 183.00% | |||
| EBIT | -11.72% | 204.95% | |||
| EBITDA | -12.11% | 113.33% | |||
| EPS Basic | -60.17% | 183.03% | |||
| Normalized Basic EPS | -11.05% | 17,300.00% | |||
| EPS Diluted | -57.53% | 197.96% | |||
| Normalized Diluted EPS | -10.65% | 17,000.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||